Engineering gene circuits for mammalian cell-based applications

Cold Spring Harbor Perspectives in Biology

Volumn 8, Issue 7, 2016, Pages

  Ausländer, Simon ^a   Fussenegger, Martin ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION;

ANIMALS; GENE REGULATORY NETWORKS; TRANSCRIPTION, GENETIC;

EID: 84977589267     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a023895     Document Type: Article

References (96)

1. Airan RD, Thompson KR, Fenno LE, Bernstein H, Deisseroth K. 2009. Temporally precise in vivo control of intracellular signalling. Nature 458: 1025-1029.
2. Ausländer S, Fussenegger M. 2013. From gene switches to mammalian designer cells: Present and future prospects. Trends Biotechnol 31: 155-168.
3. Ausländer S, Ketzer P, Hartig JS. 2010. A ligand-dependent hammerhead ribozyme switch for controlling mammalian gene expression. Mol Biosyst 6: 807-814.
4. Ausländer D, Wieland M, Ausländer S, Tigges M, Fussenegger M. 2011. Rational design of a small molecule-responsive intramer controlling transgene expression in mammalian cells. Nucleic Acids Res 39: e155.
5. Ausländer S, Ausländer D, Müller M, Wieland M, Fussenegger M. 2012a. Programmable single-cell mammalian biocomputers. Nature 487: 123-127.
6. Ausländer S, Wieland M, Fussenegger M. 2012b. Smart medication through combination of synthetic biology and cell microencapsulation. Metab Eng 14: 252-260.
7. Ausländer D, Ausländer S, Charpin-El Hamri G, Sedlmayer F, Müller M, Frey O, Hierlemann A, Stelling J, Fussenegger M. 2014a. A synthetic multifunctional mammalian pH sensor and CO2 transgene-control device. Mol Cell 55: 397-408.
8. Ausländer D, Eggerschwiler B, Kemmer C, Geering B, Ausländer S, Fussenegger M. 2014b. A designer cell-based histamine-specific human allergy profiler. Nat Commun 5: 4408.
9. Ausländer S, Stucheli P, Rehm C, Ausländer D, Hartig JS, Fussenegger M. 2014c. A general design strategy for protein-responsive riboswitches in mammalian cells. Nat Method 11: 1154-1160.
10. Bacchus W, Lang M, El-Baba MD, Weber W, Stelling J, Fussenegger M. 2012. Synthetic two-way communication between mammalian cells. Nat Biotechnol 30: 991-996.
11. Bacchus W, Weber W, Fussenegger M. 2013. Increasing the dynamic control space of mammalian transcription devices by combinatorial assembly of homologous regulatory elements from different bacterial species. Metab Eng 15: 144-150.
12. Beerli RR, Schopfer U, Dreier B, Barbas CF III. 2000. Chemically regulated zinc finger transcription factors. J Biol Chem 275: 32617-32627.
13. Benenson Y. 2012. Biomolecular computing systems: Principles, progress and potential. Nat Rev Genet 13: 455-468.
14. Burrill DR, Inniss MC, Boyle PM, Silver PA. 2012. Synthetic memory circuits for tracking human cell fate. Genes Dev 26: 1486-1497.
15. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
16. Culler SJ, Hoff KG, Smolke CD. 2010. Reprogramming cellular behavior with RNAcontrollers responsive to endogenous proteins. Science 330: 1251-1255.
17. Cuthbertson L, Nodwell JR. 2013. The TetR family of regulators. Microbiol Mol Biol Rev 77: 440-475.
18. Deans TL, Cantor CR, Collins JJ. 2007. A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell 130: 363-372.
19. Doudna JA, Charpentier E. 2014. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346: 1258096.
20. Endo K, Hayashi K, Inoue T, Saito H. 2013. Aversatile cisacting inverter module for synthetic translational switches. Nat Commun 4: 2393.
21. Famulok M, Hartig JS, Mayer G. 2007. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem Rev 107: 3715-3743.
22. Folcher M, Oesterle S, Zwicky K, Thekkottil T, Heymoz J, Hohmann M, Christen M, Daoud El-Baba M, Buchmann P, Fussenegger M. 2014. Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant. Nat Commun 5: 5392.
23. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, Thompson CJ, Bailey JE. 2000. Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18: 1203-1208.
24. Gaj T, Gersbach CA, Barbas CF III. 2013. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31: 397-405.
25. Gitzinger M, Kemmer C, El-Baba MD, Weber W, Fussenegger M. 2009. Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. Proc Natl Acad Sci 106: 10638-10643.
26. Gitzinger M, Kemmer C, Fluri DA, El-Baba MD, Weber W, Fussenegger M. 2012. The food additive vanillic acid controls transgene expression in mammalian cells and mice. Nucleic Acids Res 40: e37.
27. Goldfless SJ, Belmont BJ, de Paz AM, Liu JF, Niles JC. 2012. Direct and specific chemical control of eukaryotic translation with a synthetic RNA-protein interaction. Nucleic Acids Res 40: e64.
28. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci 89: 5547-5551.
29. Grabow WW, Jaeger L. 2014. RNA self-assembly and RNA nanotechnology. Acc Chem Res 47: 1871-1880.
30. Greber D, Fussenegger M. 2010. An engineered mammalian band-pass network. Nucleic Acids Res 38: e174.
31. Hartenbach S, Daoud-El Baba M, Weber W, Fussenegger M. 2007. An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice. Nucleic Acids Res 35: e136.
32. Heng BC, Aubel D, Fussenegger M. 2013. An overviewof the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnol Adv 31: 1676-1694.
33. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262-1278.
34. Kashida S, Inoue T, Saito H. 2012. Three-dimensionally designed protein-responsive RNA devices for cell signaling regulation. Nucleic Acids Res 40: 9369-9378.
35. Kemmer C, Gitzinger M, Daoud-El Baba M, Djonov V, Stelling J, Fussenegger M. 2010. Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat Biotechnol 28: 355-360.
36. Kemmer C, Fluri DA, Witschi U, Passeraub A, Gutzwiller A, Fussenegger M. 2011. A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms. J Control Release 150: 23-29.
37. Kim T, Folcher M, Doaud-El Baba M, Fussenegger M. 2015. A synthetic erectile optogenetic stimulator enabling bluelight-inducible penile erection. Angew Chem Int Ed Engl 54: 5933-5938.
38. Konermann S, Brigham MD, Trevino AE, Hsu PD, Heidenreich M, Cong L, Platt RJ, Scott DA, Church GM, Zhang F. 2013. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500: 472-476.
39. Kramer BP, Fussenegger M. 2005. Hysteresis in a synthetic mammalian gene network. ProcNatl Acad Sci 102: 9517-9522.
40. Kramer BP, Fischer C, Fussenegger M. 2004. BioLogic gates enable logical transcription control in mammalian cells. Biotechnol Bioeng 87: 478-484.
41. Kumar D, An CI, Yokobayashi Y. 2009. Conditional RNA interference mediated by allosteric ribozyme. J Am Chem Soc 131: 13906-13907.
42. Lapique N, Benenson Y. 2014. Digital switching in a biosensor circuit via programmable timing of gene availability. Nat Chem Biol 10: 1020-1027.
43. Leisner M, Bleris L, Lohmueller J, Xie Z, Benenson Y. 2010. Rationally designed logic integration of regulatory signals in mammalian cells. Nat Nanotechnol 5: 666-670.
44. Lienert F, Torella JP, Chen JH, Norsworthy M, Richardson RR, Silver PA. 2013. Two-and three-input TALE-based AND logic computation in embryonic stem cells. Nucleic Acids Res 41: 9967-9975.
45. Lohmueller JJ, Armel TZ, Silver PA. 2012. A tunable zinc finger-based framework for Boolean logic computation in mammalian cells. Nucleic Acids Res 40: 5180-5187.
46. Malyshev DA, Dhami K, Lavergne T, Chen T, Dai N, Foster JM, Correa IR Jr, Romesberg FE. 2014. A semi-synthetic organismwith an expanded genetic alphabet. Nature 509: 385-388.
47. Mandell DJ, Lajoie MJ, Mee MT, Takeuchi R, Kuznetsov G, Norville JE, Gregg CJ, Stoddard BL, Church GM. 2015. Biocontainment of genetically modified organisms by synthetic protein design. Nature 518: 55-60.
48. Mercer AC, Gaj T, Sirk SJ, Lamb BM, Barbas CF 3rd. 2014. Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors. ACS Synth Biol 3: 723-730.
49. Mittal V. 2004. Improving the efficiency of RNA interference in mammals. Nat Rev Genet 5: 355-365.
50. Müller M, Ausländer S, Ausländer D, Kemmer C, Fussenegger M. 2012. A novel reporter system for bacterial and mammalian cells based on the non-ribosomal peptide indigoidine. Met Eng 14: 325-335.
51. Müller K, Engesser R, Metzger S, Schulz S, Kampf MM, Busacker M, Steinberg T, Tomakidi P, Ehrbar M, Nagy F, et al. 2013a. A red/far-red light-responsive bi-stable toggle switch to control gene expression in mammalian cells. Nucleic Acids Res 41: e77.
52. Müller K, Engesser R, Schulz S, Steinberg T, Tomakidi P, Weber CC, Ulm R, Timmer J, Zurbriggen MD, Weber W. 2013b. Multi-chromatic control of mammalian gene expression and signaling. Nucleic Acids Res 41: e124.
53. Neddermann P, Gargioli C, Muraglia E, Sambucini S, Bonelli F, De Francesco R, Cortese R. 2003. A novel, inducible, eukaryotic gene expression system based on the quorum-sensing transcription factor TraR. EMBO Rep 4: 159-165.
54. Nern A, Pfeiffer BD, Svoboda K, Rubin GM. 2011.Multiple new site-specific recombinases for use in manipulating animal genomes. Proc Natl Acad Sci 108: 14198-14203.
55. Nissim L, Bar-Ziv RH. 2010. A tunable dual-promoter integrator for targeting of cancer cells. Mol Syst Biol 6: 444.
56. Nomura Y, Kumar D, Yokobayashi Y. 2012. Synthetic mammalian riboswitches based on guanine aptazyme. Chem Commun (Camb) 48: 7215-7217.
57. Nomura Y, Zhou L, Miu A, Yokobayashi Y. 2013. Controlling mammalian gene expression by allosteric hepatitis delta virus ribozymes. ACS Synth Biol 2: 684-689.
58. Park JS, Rhau B, Hermann A, McNally KA, Zhou C, Gong D, Weiner OD, Conklin BR, Onuffer J, Lim WA. 2014. Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal. Proc Natl Acad Sci 111: 5896-5901.
59. Polstein LR, Gersbach CA. 2012. Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors. J Am Chem Soc 134: 16480-16483.
60. Polstein LR, Gersbach CA. 2015. A light-inducible CRISPRCas9 system for control of endogenous gene activation. Nat Chem Biol 11: 198-200.
61. Prochazka L, Angelici B, Haefliger B, Benenson Y. 2014. Highly modular bow-tie gene circuits with programmable dynamic behaviour. Nat Commun 5: 4729.
62. Ramos JL, Martinez-Bueno M, Molina-Henares AJ, Teran W, Watanabe K, Zhang X, Gallegos MT, Brennan R, Tobes R. 2005. The TetR family of transcriptional repressors. Microbiol Mol Biol Rev 69: 326-356.
63. Rinaudo K, Bleris L, Maddamsetti R, Subramanian S, Weiss R, Benenson Y. 2007. A universal RNAi-based logic evaluator that operates in mammalian cells. Nat Biotechnol 25: 795-801.
64. Rössger K, Charpin-El Hamri G, Fussenegger M. 2013a. Reward-based hypertension control by a synthetic braindopamine interface. Proc Natl Acad Sci 110: 18150-18155.
65. Rössger K, Charpin-El-Hamri G, Fussenegger M. 2013b. A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice. Nat Commun 4: 2825.
66. Rovner AJ, Haimovich AD, Katz SR, Li Z, Grome MW, Gassaway BM, Amiram M, Patel JR, Gallagher RR, Rinehart J, et al. 2015. Recoded organisms engineered to depend on synthetic amino acids. Nature 518: 89-93.
67. Saito H, Inoue T. 2009. Synthetic biology with RNA motifs. Int J Biochem Cell Biol 41: 398-404.
68. Saito H, Kobayashi T, Hara T, Fujita Y, Hayashi K, Furushima R, Inoue T. 2010. Synthetic translational regulation by an L7Ae-kink-turn RNP switch. Nat Chem Biol 6: 71-78.
69. Saito H, Fujita Y, Kashida S, Hayashi K, Inoue T. 2011. Synthetic human cell fate regulation by protein-driven RNA switches. Nat Commun 2: 160.
70. Saxena P, Charpin-El Hamri G, Folcher M, Zulewski H, Fussenegger M. 2016. Synthetic gene network restoring endogenous pituitary-thyroid feedback control in experimental Graves’ disease. Proc Natl Acad Sci 113: 1244-1249.
71. Schukur L, Geering B, Charpin-El Hamri G, Fussenegger M. 2015. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis. Sci Transl Med 7: 318ra201.
72. Shechner DM, Hacisuleyman E, Younger ST, Rinn JL. 2015. Multiplexable, locus-specific targeting of longRNAs with CRISPR-Display. Nat Methods 12: 664-670.
73. Stanley SA, Gagner JE, Damanpour S, Yoshida M, Dordick JS, Friedman JM. 2012. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 336: 604-608.
74. Stapleton JA, Endo K, Fujita Y, Hayashi K, Takinoue M, Saito H, Inoue T. 2012. Feedback control of protein expression in mammalian cells by tunable synthetic translational inhibition. ACS Synth Biol 1: 83-88.
75. Tigges M, Marquez-Lago TT, Stelling J, Fussenegger M. 2009. A tunable synthetic mammalian oscillator. Nature 457: 309-312.
76. Urban DJ, Roth BL. 2015. DREADDs (designer receptors exclusively activated by designer drugs): Chemogenetic tools with therapeutic utility. Annu Rev Pharmacol Toxicol 55: 399-417.
77. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. 2000. Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci 97: 7963-7968.
78. Weber W, Fussenegger M. 2012. Emerging biomedical applications of synthetic biology. Nat Rev Genet 13: 21-35.
79. Weber W, Fux C, Daoud-el Baba M, Keller B, Weber CC, Kramer BP, Heinzen C, Aubel D, Bailey JE, Fussenegger M. 2002. Macrolide-based transgene control in mammalian cells and mice. Nat Biotechnol 20: 901-907.
80. Weber W, Schoenmakers R, Spielmann M, El-Baba MD, Folcher M, Keller B, Weber CC, Link N, van de Wetering P, Heinzen C, et al. 2003. Streptomyces-derived quorumsensing systems engineered for adjustable transgene expression in mammalian cells and mice. Nucleic Acids Res 31: e71.
81. Weber W, Link N, Fussenegger M. 2006. A genetic redox sensor for mammalian cells. Metab Eng 8: 273-280.
82. Weber W, Kramer BP, Fussenegger M. 2007. A genetic timedelay circuitry in mammalian cells. Biotechnol Bioeng 98: 894-902.
83. Weber W, Lienhart C, Baba MD, Fussenegger M. 2009. A biotin-triggered genetic switch in mammalian cells and mice. Metab Eng 11: 117-124.
84. Wess J, Nakajima K, Jain S. 2013.Novel designer receptors to probe GPCR signaling and physiology. Trends Pharmacol Sci 34: 385-392.
85. Wieland M, Fussenegger M. 2010. Ligand-dependent regulatory RNA parts for synthetic biology in eukaryotes. Curr Opin Biotechnol 21: 760-765.
86. Wieland M, Fussenegger M. 2012. Engineering molecular circuits using synthetic biology in mammalian cells. Annu Rev Chem Biomol Eng 3: 209-234.
87. Wieland M, Ausländer D, Fussenegger M. 2012. Engineering of ribozyme-based riboswitches for mammalian cells. Methods 56: 351-357.
88. Win MN, Smolke CD. 2007.Amodular and extensibleRNAbased gene-regulatory platform for engineering cellular function. Proc Natl Acad Sci 104: 14283-14288.
89. Win MN, Smolke CD. 2008. Higher-order cellular information processing with synthetic RNA devices. Science 322: 456-460.
90. Wunnicke D, Strohbach D, Weigand JE, Appel B, Feresin E, Suess B, Müller S, Steinhoff HJ. 2011. Ligand-induced conformational capture of a synthetic tetracycline riboswitch revealed by pulse EPR. RNA 17: 182-188.
91. Xie Z, Wroblewska L, Prochazka L, Weiss R, Benenson Y. 2011. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333: 1307-1311.
92. Xie M, Ye H, Hamri GC, Fussenegger M. 2014. Antagonistic control of a dual-input mammalian gene switch by food additives. Nucleic Acids Res 42: e116.
93. Ye H, Daoud-El Baba M, Peng RW, Fussenegger M. 2011. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332: 1565-1568.
94. Ye H, Charpin-El Hamri G, Zwicky K, Christen M, Folcher M, Fussenegger M. 2013. Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proc Natl Acad Sci 110: 141-146.
95. Zalatan JG, Lee ME, Almeida R, Gilbert LA, Whitehead EH, La Russa M, Tsai JC, Weissman JS, Dueber JE, Qi LS, et al. 2015. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160: 339-350.
96. Zetsche B, Volz SE, Zhang F. 2015. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol 33: 139-142.